2018
DOI: 10.2217/cer-2017-0094
|View full text |Cite
|
Sign up to set email alerts
|

Cost assessment of treatment of acute myocardial infarction and angiographically visible coronary thrombus

Abstract: A complex pharmaco-interventional strategy, with glycoprotein IIB/IIIA inhibitor and MT, though more expensive, may prove cost-effective.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 27 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?